Tesamorelin is a synthetic peptide analog of Growth Hormone–Releasing Hormone (GHRH), specifically engineered as a stabilized form of GHRH 1–44.

Researchers study Tesamorelin for its interactions with GHRH receptors, growth-hormone signaling pathways, metabolic activity, and endocrine regulation models.

GENIQ provides Tesamorelin exclusively for scientific research—not for human or animal use.